- Home
- MRUS vs BXMT Comparison
MRUS vs BXMT Comparison
Compare MRUS & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- BXMT
- Stock Information
- Founded
- MRUS 2003
- BXMT 1966
- Country
- MRUS Netherlands
- BXMT United States
- Employees
- MRUS N/A
- BXMT N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- BXMT Real Estate Investment Trusts
- Sector
- MRUS Health Care
- BXMT Real Estate
- Exchange
- MRUS Nasdaq
- BXMT Nasdaq
- Market Cap
- MRUS 4.1B
- BXMT 3.3B
- IPO Year
- MRUS 2016
- BXMT N/A
- Fundamental
- Price
- MRUS $52.90
- BXMT $19.16
- Analyst Decision
- MRUS Strong Buy
- BXMT Buy
- Analyst Count
- MRUS 12
- BXMT 7
- Target Price
- MRUS $87.92
- BXMT $20.50
- AVG Volume (30 Days)
- MRUS 1.2M
- BXMT 1.3M
- Earning Date
- MRUS 07-31-2025
- BXMT 07-30-2025
- Dividend Yield
- MRUS N/A
- BXMT 9.77%
- EPS Growth
- MRUS N/A
- BXMT N/A
- EPS
- MRUS N/A
- BXMT N/A
- Revenue
- MRUS $54,732,000.00
- BXMT $123,138,000.00
- Revenue This Year
- MRUS $75.57
- BXMT N/A
- Revenue Next Year
- MRUS $31.84
- BXMT $10.44
- P/E Ratio
- MRUS N/A
- BXMT N/A
- Revenue Growth
- MRUS 42.77
- BXMT N/A
- 52 Week Low
- MRUS $33.19
- BXMT $16.51
- 52 Week High
- MRUS $62.98
- BXMT $21.24
- Technical
- Relative Strength Index (RSI)
- MRUS 54.86
- BXMT 61.62
- Support Level
- MRUS $52.53
- BXMT $19.58
- Resistance Level
- MRUS $54.81
- BXMT $19.97
- Average True Range (ATR)
- MRUS 1.70
- BXMT 0.31
- MACD
- MRUS -0.55
- BXMT 0.07
- Stochastic Oscillator
- MRUS 39.04
- BXMT 86.76
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About BXMT Blackstone Mortgage Trust Inc.
Blackstone Mortgage Trust Inc is a real estate finance company involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.